Smoking status impacts treatment efficacy in smoke-induced lung inflammation: A pre-clinical study.

Front Pharmacol · 2022 · PMC9490227 · PMID 36160400

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Therefore, the impact of smoking history and treatment timing on therapeutic efficacy may be significant and the need for treatments that can help resolve pulmonary inflammation during smoking cessation would be of great value in COPD patients.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.